Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-09-005139
Filing Date
2009-03-23
Accepted
2009-03-23 12:48:18
Documents
10
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K y01284e10vk.htm 10-K 1363939
2 EX-10.44: AMENDMENT 1 TO CLINICAL TRIALS AGREEMENT y01284exv10w44.htm EX-10.44 16210
3 EX-10.45: AMENDMENT 2 TO CLINICAL TRIALS AGREEMENT y01284exv10w45.htm EX-10.45 13099
4 EX-21.1: SUBSIDIARIES y01284exv21w1.htm EX-21.1 2710
5 EX-23.1: CONSENT OF ERNST & YOUNG LLP y01284exv23w1.htm EX-23.1 3926
6 EX-31.1: CERTIFICATION y01284exv31w1.htm EX-31.1 8875
7 EX-31.2: CERTIFICATION y01284exv31w2.htm EX-31.2 8896
8 EX-32.1: CERTIFICATION y01284exv32w1.htm EX-32.1 3806
9 EX-32.2: CERTIFICATION y01284exv32w2.htm EX-32.2 3816
10 GRAPHIC y01284y0128401.gif GRAPHIC 8545
  Complete submission text file 0000950123-09-005139.txt   1438688
Mailing Address FOUR SCIENCE PARK NEW HAVEN CT 06511
Business Address 4 SCIENCE PARK NEW HAVEN CT 06511 2034984210
VION PHARMACEUTICALS INC (Filer) CIK: 0000944522 (see all company filings)

EIN.: 133671221 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26534 | Film No.: 09698250
SIC: 2836 Biological Products, (No Diagnostic Substances)